During the last session, HCW Biologics Inc (NASDAQ:HCWB)’s traded shares were 0.53 million, with the beta value of the company hitting 0.83. At the end of the trading day, the stock’s price was $0.40, reflecting an intraday loss of -2.32% or -$0.01. The 52-week high for the HCWB share is $2.52, that puts it down -530.0 from that peak though still a striking 47.5% gain since the share price plummeted to a 52-week low of $0.21. The company’s market capitalization is $15.13M, and the average intraday trading volume over the past 10 days was 36.3 million shares, and the average trade volume was 15.70 million shares over the past three months.
HCW Biologics Inc (NASDAQ:HCWB) trade information
HCW Biologics Inc (HCWB) registered a -2.32% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -2.32% in intraday trading to $0.40, hitting a weekly high. The stock’s 5-day price performance is -18.01%, and it has moved by 11.45% in 30 days. Based on these gigs, the overall price performance for the year is -66.09%. The short interest in HCW Biologics Inc (NASDAQ:HCWB) is 83110.0 shares and it means that shorts have 0.32 day(s) to cover.
HCW Biologics Inc (HCWB) estimates and forecasts
In the rating firms’ projections, revenue will increase 222.75% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 7M as predicted by 1 analyst(s).
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -34.57%. While earnings are projected to return 18.57% in 2025, the next five years will return 8.29% per annum.
HCWB Dividends
HCW Biologics Inc is due to release its next quarterly earnings in March. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
HCW Biologics Inc (NASDAQ:HCWB)’s Major holders
HCW Biologics Inc insiders own 44.42% of total outstanding shares while institutional holders control 2.73%, with the float percentage being 4.92%. AVANTAX PLANNING PARTNERS, INC. is the largest shareholder of the company, while 20.0 institutions own stock in it. As of 2024-06-30, the company held over 0.28 million shares (or 0.751% of all shares), a total value of $0.18 million in shares.
The next largest institutional holding, with 0.18 million shares, is of HIGHTOWER ADVISORS, LLC’s that is approximately 0.4857% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $0.12 million.
Also, the Mutual Funds coming in first place with the largest holdings of HCW Biologics Inc (HCWB) shares are Fidelity Extended Market Index Fund and Bridgeway Funds Inc-Ultra Small Company Market Fund . Data provided on Nov 30, 2024 indicates that Fidelity Extended Market Index Fund owns about 94.58 shares. This amounts to just over 0.25 percent of the company’s overall shares, with a $37843.0 market value. The same data shows that the other fund manager holds slightly less at 84.7, or about 0.22% of the stock, which is worth about $33888.0.
